Report from the 5th cardiovascular outcome trial (CVOT) summit
Abstract The 5th Cardiovascular Outcome Trial (CVOT) Summit was held in Munich on October 24th–25th, 2019. As in previous years, this summit served as a reference meeting for in-depth discussions on the topic of recently completed and presented CVOTs. This year, focus was placed on the CVOTs CAROLIN...
| Published in: | Cardiovascular Diabetology |
|---|---|
| Main Authors: | Oliver Schnell, Eberhard Standl, Xavier Cos, Hiddo JL Heerspink, Baruch Itzhak, Nebojsa Lalic, Michael Nauck, Antonio Ceriello |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2020-04-01
|
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s12933-020-01022-7 |
Similar Items
Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes
by: Oliver Schnell, et al.
Published: (2022-04-01)
by: Oliver Schnell, et al.
Published: (2022-04-01)
Correction to: Report from the 2nd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes and Cardiovascular Disease (D&CVD) EASD Study Group
by: Oliver Schnell, et al.
Published: (2017-10-01)
by: Oliver Schnell, et al.
Published: (2017-10-01)
Rationale for dapagliflozin administration for the prevention of adverse outcomes in patients with heart failure with reduced ejection fraction. Expert consensus statement
by: S. N. Tereshchenko, et al.
Published: (2020-06-01)
by: S. N. Tereshchenko, et al.
Published: (2020-06-01)
CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes
by: Oliver Schnell, et al.
Published: (2023-03-01)
by: Oliver Schnell, et al.
Published: (2023-03-01)
CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes
by: Oliver Schnell, et al.
Published: (2024-03-01)
by: Oliver Schnell, et al.
Published: (2024-03-01)
DAPA-HF trial: dapagliflozin evolves from a glucose-lowering agent to a therapy for heart failure
by: Edgardo Kaplinsky
Published: (2020-02-01)
by: Edgardo Kaplinsky
Published: (2020-02-01)
PDM-ProValue meets cardiovascular outcome trials in diabetes
by: Katharina Fritzen, et al.
Published: (2019-01-01)
by: Katharina Fritzen, et al.
Published: (2019-01-01)
CVOT summit report 2024: new cardiovascular, kidney, and metabolic outcomes
by: Oliver Schnell, et al.
Published: (2025-05-01)
by: Oliver Schnell, et al.
Published: (2025-05-01)
Electrical Features of the Diabetic Myocardium. Arrhythmic and Cardiovascular Safety Considerations in Diabetes
by: Mónica Gallego, et al.
Published: (2021-07-01)
by: Mónica Gallego, et al.
Published: (2021-07-01)
Patterns of new glucagon‐like peptide‐1 receptor agonist use in patients with type 2 diabetes during 2014–2019 from a US database: prescriber and patient characteristics
by: Ildiko Lingvay, et al.
Published: (2023-02-01)
by: Ildiko Lingvay, et al.
Published: (2023-02-01)
The Kidney Protective Effects of the Sodium–Glucose Cotransporter-2 Inhibitor, Dapagliflozin, Are Present in Patients With CKD Treated With Mineralocorticoid Receptor Antagonists
by: Michele Provenzano, et al.
Published: (2022-03-01)
by: Michele Provenzano, et al.
Published: (2022-03-01)
Towards quadruple therapy for heart failure with reduced ejection fraction: DAPA-HF secondary analysis data
by: Zh. D. Kobalava, et al.
Published: (2020-06-01)
by: Zh. D. Kobalava, et al.
Published: (2020-06-01)
An introduction to Decision Theory for Belief
by: MATHEUS RUI
Published: (2024-11-01)
by: MATHEUS RUI
Published: (2024-11-01)
Le système du croire. Crédence et croyance
by: Tiziana Migliore
Published: (2021-01-01)
by: Tiziana Migliore
Published: (2021-01-01)
Reputation and Production Standards
by: Jill J. McCluskey, et al.
Published: (2005-04-01)
by: Jill J. McCluskey, et al.
Published: (2005-04-01)
Epidemiology, clinical profile, management, and two-year risk complications among patients with chronic kidney disease in Spain
by: Carlos Escobar, et al.
Published: (2021-11-01)
by: Carlos Escobar, et al.
Published: (2021-11-01)
Why Credences Cannot be Imprecise
by: Borut Trpin
Published: (2014-10-01)
by: Borut Trpin
Published: (2014-10-01)
Research on secure routing algorithm in satellite networks
by: LI Zhe, et al.
Published: (2006-01-01)
by: LI Zhe, et al.
Published: (2006-01-01)
Research on secure routing algorithm in satellite networks
by: LI Zhe, et al.
Published: (2006-01-01)
by: LI Zhe, et al.
Published: (2006-01-01)
Dapagliflozin attenuates atrial fibrosis via the HMGB1/RAGE pathway in atrial fibrillation rats
by: Tan Zhenni, et al.
Published: (2025-09-01)
by: Tan Zhenni, et al.
Published: (2025-09-01)
Sub-analyses of the DAPA-CKD study: new data on the use of sodium-glucose cotransporter type 2 inhibitor in the treatment of chronic kidney disease
by: Minara S. Shamkhalova, et al.
Published: (2022-11-01)
by: Minara S. Shamkhalova, et al.
Published: (2022-11-01)
Expanding the Use of SGLT2 Inhibitors in T2D Patients Across Clinical Settings
by: Alessandro Cuttone, et al.
Published: (2025-05-01)
by: Alessandro Cuttone, et al.
Published: (2025-05-01)
Risk of stroke and retinopathy during GLP-1 receptor agonist cardiovascular outcome trials: An eight RCTs meta-analysis
by: Jinjing Wei, et al.
Published: (2022-12-01)
by: Jinjing Wei, et al.
Published: (2022-12-01)
Ethical, moral and social dimensions in farm production practices: a segmentation study to assess Irish consumers’ perceptions of meat quality
by: Regan Á., et al.
Published: (2018-03-01)
by: Regan Á., et al.
Published: (2018-03-01)
Food Credence Attributes: A Conceptual Framework of Supply Chain Stakeholders, Their Motives, and Mechanisms to Address Information Asymmetry
by: Peggy Schrobback, et al.
Published: (2023-01-01)
by: Peggy Schrobback, et al.
Published: (2023-01-01)
Governance Structure, Perception, and Innovation in Credence Food Transactions: The Role of Food Community Networks
by: Stefano Pascucci
Published: (2010-10-01)
by: Stefano Pascucci
Published: (2010-10-01)
Cardiovascular outcomes trials: a paradigm shift in the current management of type 2 diabetes
by: Melanie J. Davies, et al.
Published: (2022-08-01)
by: Melanie J. Davies, et al.
Published: (2022-08-01)
The Subjective Probability of Conditionals and Its Formalizations
by: Anna Wójtowicz, et al.
Published: (2023-12-01)
by: Anna Wójtowicz, et al.
Published: (2023-12-01)
Two Concepts of Belief Strength: Epistemic Confidence and Identity Centrality
by: Neil Van Leeuwen
Published: (2022-06-01)
by: Neil Van Leeuwen
Published: (2022-06-01)
Credence in the Organization’s Ability to Respond to Change – Implications on Work Engagement and Job Satisfaction in the Church of Sweden
by: Anders Edvik, et al.
Published: (2020-06-01)
by: Anders Edvik, et al.
Published: (2020-06-01)
CAROLINA RODRÍGUEZ RODRÍGUEZ In memoriam
by: Carlos H. Marín Ospina
Published: (2012-01-01)
by: Carlos H. Marín Ospina
Published: (2012-01-01)
Consumer attitudes towards origin and organic - the role of credence labels on consumers' liking of tomatoes
by: F. Fernqvist, et al.
Published: (2013-01-01)
by: F. Fernqvist, et al.
Published: (2013-01-01)
Considering Fraud Vulnerability Associated with Credence-Based Products Such as Organic Food
by: Louise Manning, et al.
Published: (2021-08-01)
by: Louise Manning, et al.
Published: (2021-08-01)
O autobiografskim zapisima Antuna Hrvatina, Ivana Aničića i Katarine Šćuka-Kukec iz fondova Državnog arhiva u Pazinu
by: Iva Grdinić, et al.
Published: (2019-11-01)
by: Iva Grdinić, et al.
Published: (2019-11-01)
Results of the DAPA-CKD trial and their impact on clinical practice
by: O.V. Bilchenko
Published: (2023-06-01)
by: O.V. Bilchenko
Published: (2023-06-01)
Arrolamento das fontes primárias para a História do Estado do Maranhão: Carolina
by: Josué Callender dos Reis
Published: (1972-09-01)
by: Josué Callender dos Reis
Published: (1972-09-01)
Enhancing Customer Happiness Through Corporate Social Responsibility: Unveiling the Impact of CSR on Customer Well-Being
by: Cheonglim Lee, et al.
Published: (2024-01-01)
by: Cheonglim Lee, et al.
Published: (2024-01-01)
Payment Systems, Supplier-Induced Demand, and Service Quality in Credence Goods: Results from a Laboratory Experiment
by: Manela Karunadasa, et al.
Published: (2023-05-01)
by: Manela Karunadasa, et al.
Published: (2023-05-01)
The effects of purchase and consumption on beef quality attribute beliefs: a study of tourists visiting Vanuatu
by: Nic Lees, et al.
Published: (2024-12-01)
by: Nic Lees, et al.
Published: (2024-12-01)
Governance and trust in sustainability-based agri-food value chains. A comparative analysis of five cases in Germany
by: Pascal Grohmann, et al.
Published: (2023-06-01)
by: Pascal Grohmann, et al.
Published: (2023-06-01)
Similar Items
-
Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes
by: Oliver Schnell, et al.
Published: (2022-04-01) -
Correction to: Report from the 2nd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes and Cardiovascular Disease (D&CVD) EASD Study Group
by: Oliver Schnell, et al.
Published: (2017-10-01) -
Rationale for dapagliflozin administration for the prevention of adverse outcomes in patients with heart failure with reduced ejection fraction. Expert consensus statement
by: S. N. Tereshchenko, et al.
Published: (2020-06-01) -
CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes
by: Oliver Schnell, et al.
Published: (2023-03-01) -
CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes
by: Oliver Schnell, et al.
Published: (2024-03-01)
